PROFESSIONAL EXPERIENCE
MAGGIO 2021 – OCTOBER 2021 | ASL ROMA 5
Anti SARS-CoV-2 vaccination campaign
2021 – 2025 | AGOSTINO GEMELLI UNIVERSITY POLYCLINICAL FOUNDATION, IRCCS
School of Specialization in Otolaryngology, UOC Otolaryngology – Audiology and Phoniatrics
DECEMBER 2023 – JANUARY 2024 | TIBERINA ISLAND HOSPITAL – GEMINI ISLAND
UOC Otolaryngology
MARZO 2024 – APRIL 2024 | SAN FILIPPO NERI HOSPITAL
UOC Otolaryngology
OCTOBER 2024 – DECEMBER 2024 | CHILD JESUS PEDIATRIC HOSPITAL, IRCCS
UOC Otolaryngology – Audiology and Phoniatrics
FEBRUARY 2023 – JANUARY 2025 | AGOSTINO GEMELLI UNIVERSITY POLICLINICO, IRCCS
Sub-investigator Trial Clinico EVEREST LPS16747 – Sanofi.
FEBRUARY 2024 – OCTOBER 2025 | AGOSTINO GEMELLI UNIVERSITY POLICLINICO, IRCCS
Sub-investigator MEPOREAL observational study – GSK.
JUNE 2025 – OCTOBER 2025 | AGOSTINO GEMELLI UNIVERSITY POLICLINICO, IRCCS
Sub-investigator Trial Clinico ESSENCE D5242C00002 – Astrazeneca AB.
NOVEMBER 2025 | ASL ROMA 2
Otolaryngology Outpatient Replacements
ISTRUZIONE E FORMAZIONE
2014 – 2020 | UNIVERSITY OF L'AQUILA
Master's Degree in Medicine and Surgery Vote: 110/110 with Lode
2021 – 2025 | CATHOLIC UNIVERSITY OF THE SACRED HEART
Specialization in Otolaryngology Rating: 50/50 with Lode
25 – 26 – 27 MARZO 2024
12° Advanced Master of Nasal Cytology
6 – 7 – 8 MARZO 2023
11° Advanced Master of Nasal Cytology
SKILLS AND SKILLS
Complete management, from diagnosis to treatment, of acute and chronic inflammatory pathologies of the nasal-sinus area, of the middle and external ear, of the salivary glands, of the oral cavity, of the upper aero-digestive tracts and the lateral cervical region.
Diagnosis and management of hearing loss, dysphonia is dysphagia, in adult and pediatric patients. Diagnosis and management of obstructive sleep apnea (Course of ENT Snoring Surgery”).
Clinical and surgical experience gained at one of the hospital centers with the largest ENT case history in Italy.
Expertise in the diagnosis and treatment of benign and malignant neoplasms of the cervico-facial area, with participation in multidisciplinary oncology courses.
Skill in endoscopic and instrumental ear diagnostics, nose and larynx. Management of vestibular pathologies and balance disorders.
Execution and assistance in rhino-sinus endoscopic surgery, laryngeal and otological microsurgery. Execution and assistance in open surgery of the oral cavity, of the neck and upper aero-digestive tracts. Participation in clinical and follow-up protocols in the oncology and inflammatory field.
Experience in managing clinical trials.
COURSES AND CONFERENCES
BASIC SCIENCE IN AUDIOLOGY AND PHONIATRY
Assago, 14 – 15 January 2022, Amplifon research and study centre
108° SIO, NATIONAL CONGRESS OF THE ITALY SOCIETY OF ENT AND NECK SURGERY – FACIAL.
SPEAKER
Roma, 25 – 28 May 2022
4TH COURSE ON SURGICAL INNOVATIONS AND NEW TECHNOLOGIES IN OBSTRUCTIVE SLEEP APNEA AND SNORING IN THE ERA OF PRECISION MEDICINE
Roma, 5 – 6 May 2023, University Campus Bio-Medico
6° SIR, NATIONAL CONGRESS OF THE ITALIAN SOCIETY OF RHINOLOGY.
SPEAKER AND WINNER OF THE COSIMO GALLETTI PRIZE FOR BEST ORAL COMMUNICATION
Messina, 4, 5 e 6 Ottobre 2023
PRACTICAL MANAGEMENT OF PATIENTS AFFECTED BY SEVERE UNCONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
SPEAKER
Roma, 19 – 20 January 2024, Gemelli University Hospital Foundation, IRCCS
RI_NAUTILUS 2024, FROM THE SCIENCE OF RHINOLOGICAL DISEASES TO DIAGNOSTIC UPDATES – THERAPEUTIC
SPEAKER
Perugia, 16 – 17 February 2024
1° ROMAN GROUP CONGRESS – LAZIALE UNDER 40 “UPDATE IN ENTRY”
Roma, 18 May 2024, University Campus Bio-Medico NP CONNECT – CENTERS OF EXCELLENCE RELATORE
Roma, 15 – 16 November 2024
DISSECTION COURSE ON TEMPORAL BONE, AFORL
Roma, 25 – 26 March 2025, Catholic University of the Sacred Heart
5TH COURSE ON SURGICAL INNOVATIONS AND NEW TECHNOLOGIES IN OBSTRUCTIVE SLEEP APNEA AND SNORING IN THE ERA OF PRECISION MEDICINE
Roma, 13 – 14 June 2025, University Campus Bio-Medico
CRSWNP PRECEPTORSHIP, PRACTICAL MANAGEMENT OF PATIENTS AFFECTED BY SEVERE UNCONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
SPEAKER
Roma, 5 – 6 September 2025
NEW BIOLOGICAL DRUGS IN NASAL POLYPOSIS. OPTIMIZE THE TREATMENT BETWEEN EFFECTIVENESS, SECURITY AND LONG-TERM STRATEGY
Roma, 31 Ottobre – 1 November 2025
SCIENTIFIC PUBLICATIONS
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment.
Turret, Sara, Eugent Of Course, Nicolò Nava, Francesca Fraccaroli, Silvia Mariel Ferrucci, Stefano Settimi, Claudio Montuori, David Paul Porron, Camilla Spano, Giuseppe D'Agostino, and et al. 2022.
Journal of Personalized Medicine 12, no. 10: 1734. https://doi.org/10.3390/jpm12101734
The role of flow cytometry for the timely diagnosis of Lymphoma in the head and neck district.
Silvia Bellesi, Antonella Fiorita, Luigi Corina, Giuseppe D'Agostino, Elena Maiolo, Emanuele Scarano, Camilla Iacovelli, ELeonora Alma, Flaminia Bellisario, Rosalia Malafronte, Francesco D'Alò, Luigi Maria Larocca, Stefan Hohaus, Jacopo Galli
Oral OncoLogy Reports, Volume 6, https://doi.org/10.1016/j.oor.2023.100045
Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP.
Octavian, G., De Corso, E., Saccardo, T., D'Auria, L. M., Zampollo, S., D’Agostino, G., Mairani, E., May, G., Scarpa, B., Sleeping, C., & Favero, V. (2023).
Journal of Personalized Medicine, 13(8), 1241. https://doi.org/10.3390/jpm13081241
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study.
DeCorso E, Montuori C, Baron S, Mastrapasqua RF, Porru DP, D'Auria LM, D’Agostino G, Penazzi D, May G, Honors ME, Sarlo F, Corbo’ M, Galli J. Epub 2023 Dec 29
Otorhinolyngol Ark. 2024 May;281(5):2429-2440. doi: 10.1007/s00405-023-08417-8.
Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.
DeCorso E, Seventh S, Penazzi D, D’Agostino G, Corbò M, Rigante M, Montuori C, Rizzuti A, Pacilli MC, By Cesare T, The Green S, Rizzi A, Chini R, Galli J.
Journal of Personalized Medicine, 2024 Jul 9;14(7):735. doi: 10.3390/jpm14070735
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps.
DeCorso E, Baron S, Seventh S, Honors ME, by Cesare T, Mastrapasqua RF, Sarlo F, Penazzi D, D’Agostino G, D'Auria LM, May G, Phaeton AR, Galli J.
Int Forum Allergy Rhinol. 2024 Jul;14(7):1195-1205. doi: 10.1002/aLr.23319. Epub 2024 Jan 24.
Comparative real-world outcomes of Dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients.
DeCorso E, Porru DP, Corbò M, Montuori C, May G, Mastrapasqua RF, Panfili M, Spanu C, By Bella GA, D’Agostino G, Rizzuti A, Pass them GC, Galli J.
Clin Otolaryngol. 2024 Jul;49(4):481-489. doi: 10.1111/coa.14172. Epub 2024 May 6.
Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease.
DeCorso E, Corbò M, Montuori C, Furno D, Section V, By Cesare T, Pipolo C, Baron S, Mastrapasqua R, Rizzuti A, D’Agostino G, D'Auria LM, Pacilli MC, Galli J.
Acta Otorhinolaryngol Ital. 2025 Feb;45(1):39-46. doi: 10.14639/0392-100X-N2877.
Dupilumab Monthly Dose De-Escalation Maintains Efficacy in CRSwNP: A Two-Year Real-World Study.
DeCorso E, Montuori C, May G, D'Auria LM, Rizzuti A, Pacilli MC, D’Agostino G, Mastrapasqua R, My YES, Galli J.
Laryngoscope. 2025 Jul;135(7):2267-2274. doi: 10.1002/Lary.32162. Epub 2025 Mar 28.
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission and Tapering Dosage.
DeCorso E, Montuori C, Pipolo C, At Mantia I, Pasquini E, Ghidini A, Section V, Ottaviano G, Canton E, Given by G, Garzaro M, Say GL, S. Tower, Anastasi F, Canevari FRM, Report card F, Transparencies D, Knight C, Pagliuca G, Maffei M, Bussu F, Corbò M, D Auria LM, May G, Loperfido A, Gallo S, D’Agostino G, Giannarelli D, Galli J; DUPIREAL Italian Study Group.
Allergy. 2025 Aug 30. doi: 10.1111/aLL.70032.